NorthWest Biotherapeutics Inc (NWBO)

[georgebailey]

Smitty as we know approval starts the clock.
I see 15-25 as being a good target on MHRA approval.
FDA application gets submitted Q3 to Q1 2025 which coincides with Eden’s app and approval.
You can change the FDA timing if you want.
Point is that with MHRA approval, FDA approval and ROW approvals become likely to happen.
15-25 BO price will become stale quickly as additional applications get filed, Eden’s becomes integrated and as additional trials begin and in process trials end.
I agree that a buyout price will be less than many investors want I just don’t thing the buyout happens for a couple years out after capture of WW approvals for Gliomas and combo trials run their course- 2-3 years.